Maravai Lifesciences Holdings (MRVI) Tax Rate Growth (3y) (2023 - 2026)
Maravai Lifesciences Holdings (MRVI) Tax Rate Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Maravai Lifesciences Holdings | 986.91 Mn | 820.99 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,788.00 |
| Dec 31, 2025 | -882.00 |
| Sep 30, 2025 | -1,220.00 |
| Jun 30, 2025 | -466.00 |
| Mar 31, 2025 | -1,228.00 |
| Dec 31, 2024 | -1,213.00 |
| Sep 30, 2024 | -1,266.00 |
| Jun 30, 2024 | 387.00 |
| Mar 31, 2024 | -1,658.00 |
| Dec 31, 2023 | 11,427.00 |
| Sep 30, 2023 | 2,749.00 |
| Jun 30, 2023 | 12,363.00 |
| Mar 31, 2023 | 5,699.00 |